1.Angiographic characteristics of acute central serous chorioretinopathy in an Asian population.
Alicia C S W HOW ; Adrian H C KOH
Annals of the Academy of Medicine, Singapore 2006;35(2):77-79
INTRODUCTIONAcute central serous chorioretinopathy (CSCR) afflicts young middle-aged males in the Western population. We aimed to analyse patient demographics and to determine the angiographic characteristics of acute CSCR in an Asian population.
MATERIALS AND METHODSThis is a retrospective study of all patients presenting with acute CSCR who had fundal fluorescein angiograms performed within a 4-year period (between 1 January 1998 and 31 December 2001).
RESULTSThe fluorescein angiograms of 128 patients were analysed. The majority were male (109/128) with a male-to-female ratio of 5.7:1. The age range of patients was 26 to 60 years, with a mean age of 41 years. The majority of patients (84%) were aged 30 to 50 years. With regard to racial distribution, 83% were Chinese, 6% were Malays and 11% were Indians or of other races. Unilateral disease was found in 74 patients (58%) and 52 had bilateral disease. The macula was the most common site of fluorescein leakage and was found in 97 patients (76%). Almost half the patients (44%) had more than one site of disease involvement (i.e., multifocal). The inkblot leakage pattern was found in 103 patients (80%).
CONCLUSIONSThe patient demographics of acute CSCR in our population were compared to that reported in the West. The gender ratio was similar, with males being afflicted 6 to 10 times more compared to females. There was no racial predilection found for acute CSCR in the local population. We also found a significant proportion of patients with bilateral and multifocal disease compared to the West. The inkblot pattern of leakage was the most common pattern seen on angiography. There were a significant number of cases with bilateral and multifocal involvement, exceeding those reported in non-Asian populations.
Acute Disease ; Adult ; Choroid Diseases ; diagnostic imaging ; Female ; Fluorescein Angiography ; Humans ; Male ; Middle Aged ; Radiography ; Retinal Diseases ; diagnostic imaging ; Retrospective Studies ; Singapore
2.Depressive Symptoms in Newly Diagnosed Lung Carcinoma: Prevalence and Associated Risk Factors
K K SHAHEDAH ; S H HOW ; A R JAMALLUDIN ; M T MOHD FAIZ ; Y C KUAN ; C K ONG
Tuberculosis and Respiratory Diseases 2019;82(3):217-226
BACKGROUND: Depression is a recognized complication of lung cancer underreported in developing countries such as Malaysia. Treating and identifying depression in cancer patients increases survival and quality of life. Our objectives are to study prevalence of depressive symptoms in newly diagnosed lung carcinoma, and examine the relationship of depressive symptoms with other influencing risk factors. METHODS: A 2-year, cross sectional study February 2015–February 2017, was conducted at Hospital Tengku Ampuan Afzan, and Penang General Hospital. One hundred and three patients with newly diagnosed, biopsy confirmed primary lung carcinoma were recruited. Self-rated patient's identification sheet, validated Center for Epidemiologic Studies Depression (CES-D), and Dukes University Religion Index score from three different main languages were used. RESULTS: Prevalence of current depressive symptoms (CES-D total score ≥16) is 37.9%. The result suggests prevalence of those at high risk of moderate to major depression, may need treatment. Multivariate analysis reveals those with good Eastern Cooperation Oncology Group factor (η2=0.24, p<0.001) married (η2=0.14, p<0.001) with intrinsic religiosity (IR) (η2=0.07, p<0.02) are more resistant to depression. CONCLUSION: One in three of lung carcinoma patients, are at increased risk for depression. Clinicians should be aware that risk is highest in those with poor performance status, single, and with poor IR. We suggest routine screening of depression symptoms as it is feasible, to be performed during a regular clinic visit with immediate referral to psychiatrist when indicated.
Ambulatory Care
;
Biopsy
;
Depression
;
Developing Countries
;
Epidemiologic Studies
;
Hospitals, General
;
Humans
;
Lung Neoplasms
;
Lung
;
Malaysia
;
Mass Screening
;
Multivariate Analysis
;
Prevalence
;
Psychiatry
;
Quality of Life
;
Referral and Consultation
;
Risk Factors
3.Determination of the antimicrobial property of oregano (Plectranthus amboinicus (Lour.) Spreng.) crude aqueous leaf extract against throat pathogens using broth and checkerboard dilution methods.
Sofia Isabel T. Manlubatan ; Kara Mae H. Matias ; Kenneth Roy P. Mendoza ; Sheryll Anne R. Manalili ; Kris Conrad M. Mangunay ; Christine Mae G. Olivar ; Johnnel G. Pahila ; Greco Mark B. Malijan ; Paulo Miguel G. Manzanilla ; Marie Abigail M. Marin ; Ramon Joseph Y. Mata ; Abdel Hadi M. Mohammad Isa ; Carla Maja Lizl A. Montañ ; a ; Maika Kamille M. Mortell ; Mark Terence P. Mujer ; Patricia A. Nacianceno ; Maria Regina Rocio S. Naval ; Joseph V. Orañ ; o ; Gabriel M. Ozoa ; Alfredo P. Pacheco ; Leonila E. Casanova ; Cleotilde H. How
Acta Medica Philippina 2022;56(5):6-16
Objective: This study aimed to determine the antimicrobial property of oregano (Plectranthus amboinicus) crude leaf extract against pathogens that infect the throat, specifically Streptococcus pyogenes and Candida albicans using the broth and checkerboard dilution methods.
Methods: This study employed an experimental study design using broth dilution method for the determination of the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) against Streptococcus pyogenes ATCC 19615, and minimum fungicidal concentration (MFC) against Candida albicans ATCC 14053 of P. amboinicus crude extract (PA extract). Checkerboard dilution method was then used for determination of the synergy between PA extract and the standard antimicrobials.
Results: In vitro growth inhibition of S. pyogenes (MIC 0.13 g/mL) and C. albicans (MIC 0.03 g/mL) was exhibited by the PA extract. The highest concentration of PA extract used in this study was not sufficient to demonstrate bactericidal and fungicidal activity (MBC >0.25 g/mL, MFC >0.25 g/mL). Results of checkerboard dilution method revealed that PA extract when combined with either penicillin (for S. pyogenes) or nystatin (for C. albicans) demonstrated indifference.
Conclusion: The crude extract of Plectranthus amboinicus has the capability to inhibit the growth of both S. pyogenes and C. albicans. This demonstrates its potential use in the treatment of throat infections caused by these organisms.
Key Words: Plectranthus amboinicus, oregano, antimicrobial, throat infections, herbal medicine
Origanum ; Herbal Medicine
4.Ministry of Health Clinical Practice Guidelines: Chronic Obstructive Pulmonary Disease.
Tow Keang LIM ; Cynthia B CHEE ; Patsy CHOW ; Gerald Sw CHUA ; Soo Kiang ENG ; Soon Keng GOH ; Kwee Keng KNG ; Wai Hing LIM ; Tze Pin NG ; Thun How ONG ; S T Angeline SEAH ; Hsien Yung TAN ; K H TEE ; Vimal PALANICHAMY ; Meredith T YEUNG
Singapore medical journal 2018;59(2):76-86
The Ministry of Health (MOH) has updated the Clinical Practice Guidelines on Chronic Obstructive Pulmonary Disease (COPD) to provide doctors and patients in Singapore with evidence-based treatment for COPD. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH Clinical Practice Guidelines on COPD, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: https://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html. The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.
Adult
;
Aged
;
Evidence-Based Medicine
;
Humans
;
Middle Aged
;
Palliative Care
;
Prevalence
;
Pulmonary Disease, Chronic Obstructive
;
diagnosis
;
therapy
;
Pulmonary Medicine
;
standards
;
Quality Improvement
;
Radiography, Thoracic
;
Risk Factors
;
Singapore
;
Steroids
;
therapeutic use